ASTHMA sufferers have been told to check their inhalers after two brands have issued an urgent recall. Here's what you need to know to work out if you need to pass your puffer back. Two brands have ...

Asthma UK said that "faulty inhalers could put people's lives at risk" as it called on patients to check whether their inhaler needed to be returned. The call comes after the Medicines and Healthcare ...

A year after British pharmaceutical giant, GlaxoSmithKline exited Nigeria and asthmatic patients who depended on its inhalers faced significant distress due to the medication’s scarcity, ...

GlaxoSmithKline said yesterday its combination asthma drug Seretide had become the first drug to reduce the risk of death in patients with chronic obstructive pulmonary disease (COPD). GlaxoSmithKline ...

LONDON, July 9 (Reuters) - GlaxoSmithKline Plc has won a licence extension in Europe for Seretide, allowing its top-selling inhaler product to be used in a wider population of patients with the lung ...

Glenmark Pharmaceuticals, a Rs. 6,000 crore plus pharma major, has received approval for Salmecort (salmeterol+fluticasone) MDI inhaler, from the Ministry of Health (MoH), Russia. The combination ...

Glenmark Pharmaceuticals Europe Ltd (Glenmark) has announced that it has entered into a strategic development and licensing agreement with Poland based Celon Pharma S.A. (Celon) to develop and market ...

Mylan N.V. has announced that it has launched the first bioequivalent alternative to GlaxoSmithKline's Seretide® Evohaler® (salmeterol xinafoate/fluticasone propionate) under the brand name Sirdupla™ ...